Literature DB >> 13861628

A clinical analysis of the effects of tofranil in depression. Longitudinal and follow-up studies. Treatment of blood-relations.

J ANGST.   

Abstract

Entities:  

Keywords:  ANTIDEPRESSIVE AGENTS/pharmacology

Mesh：

Substances：

Year:  1961        PMID： 13861628     DOI： 10.1007/BF00407438

Source DB:  PubMed          Journal:  Psychopharmacologia


× No keyword cloud information.
  44 in total

1.  The treatment of depressive conditions with imipramine (G 22355).

Authors:  H E LEHMANN; C H CAHN; R L DE VERTEUIL
Journal:  Can Psychiatr Assoc J       Date:  1958-10

2.  [Induction of endogenous depressive phases by situative influences].

Authors:  B PAULEIKHOFF
Journal:  Arch Psychiatr Nervenkr Z Gesamte Neurol Psychiatr       Date:  1959

3.  [Treatment of states of depression with tofranil].

Authors:  A TSCHUDIN
Journal:  Praxis       Date:  1958-11-13

4.  [A new drug (iminodibenzylic derivative, G 22355) in therapy of depressive states].

Authors:  C FAZIO; F GIBERTI; C LOEB
Journal:  Minerva Med       Date:  1958-08-18       Impact factor: 4.806

5.  [Treatment of depressive conditions in psychiatric practice with tofranil].

Authors:  F H LEHNER
Journal:  Schweiz Med Wochenschr       Date:  1959-02-21

6.  [Study of the effectiveness of imipramine in the treatment of depressive states].

Authors:  J DELAY; P DENIKER; T LEMPERIERE; M ROPERT; W COLIN; B OGRIZEK
Journal:  Ann Med Psychol (Paris)       Date:  1959-03       Impact factor: 0.380

7.  [Treatment of depressive states with an iminodibenzyl derivative (G 22355)].

Authors:  R KUHN
Journal:  Schweiz Med Wochenschr       Date:  1957-08-31

8.  The use of imipramine (tofranil) for depressive states in open ward settings of a general hospital: a preliminary report.

Authors:  R B SLOANE; A HABIB; U E BATT
Journal:  Can Med Assoc J       Date:  1959-04-01       Impact factor: 8.262

9.  Imipramine (tofranil); a new drug for the depressed.

Authors:  H AZIMA
Journal:  Can Med Assoc J       Date:  1959-04-01       Impact factor: 8.262

10.  Involutional melancholia: an etiologic, clinical and social study of endogenous depression in later life, with special reference to genetic factors.

Authors:  A STENSTEDT
Journal:  Acta Psychiatr Neurol Scand Suppl       Date:  1959
View more
  11 in total

Review 1.  Continuation and maintenance therapy with antidepressive agents. An overview of research.

Authors:  A J Loonen; G J Zwanikken
Journal:  Pharm Weekbl Sci       Date:  1990-08-24

2.  [The future of depression research].

Authors:  F Holsboer
Journal:  Nervenarzt       Date:  2010-11       Impact factor: 1.214

3.  Personalized psychiatry: many questions, fewer answers.

Authors:  Martin Alda
Journal:  J Psychiatry Neurosci       Date:  2013-11       Impact factor: 6.186

4.  New horizons in psychopharmacology.

Authors:  W Linford
Journal:  Proc R Soc Med       Date:  1972-09

5.  Differentiation of two genetically specific types of depression by the response to antidepressant drugs.

Authors:  C M Pare; J W Mack
Journal:  J Med Genet       Date:  1971-09       Impact factor: 6.318

6.  Differentiation of two genetically specific types of depression by the response to antidepressant drugs.

Authors:  C M Pare
Journal:  Humangenetik       Date:  1970

7.  [DESIPRAMINE (PERTOFRAN) IN THE TREATMENT OF DEPRESSIONS WITH A PSYCHODYNAMIC ANALYSIS OF ITS THERAPEUTIC EFFECTS].

Authors:  R ALNAES; J KRISTIANSEN
Journal:  Arch Psychiatr Nervenkr       Date:  1964-03-16

8.  Prediction of therapeutic response in acute treatment with antidepressants. Results of an empirical study involving 159 endogenous depressive inpatients.

Authors:  H J Möller; G Fischer; D von Zerssen
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1987

9.  Polymorphisms in GRIK4, HTR2A, and FKBP5 show interactive effects in predicting remission to antidepressant treatment.

Authors:  Sonja Horstmann; Susanne Lucae; Andreas Menke; Johannes M Hennings; Marcus Ising; Darina Roeske; Bertram Müller-Myhsok; Florian Holsboer; Elisabeth B Binder
Journal:  Neuropsychopharmacology       Date:  2009-11-18       Impact factor: 7.853

10.  Brain amine concentrations after monoamine oxidase inhibitor administration.

Authors:  A B Jones; C M Pare; W J Nicholson; K Price; R S Stacey
Journal:  Br Med J       Date:  1972-01-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.